from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1779c/-

LFCtreatmentdescriptionclass of inhibitor

-0.940

Amikacinug/mL Amikacintranslation

-0.536

Cap5-10ug/mL Capreomycintranslation

0.352

Rox10-50 ug/mL Roxithromycintranslation

0.872

SM2-5 ug/mL Streptomycintranslation

-2.219

Tet5-10 ug/mL Tetracyclinetranslation

-1.157

Rif0.2-5ug/mL Rifampicintranscription

0.080

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.567

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.547

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.007

CPZ10-50 ug/mL Chlorpromazinerespiration

0.589

Clofazimine10-13 ug/mL Clofaziminerespiration

0.996

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.461

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.601

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.236

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.533

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.864

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-1.054

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.754

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.669

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.445

KCN5-20 ug/mL Potassium cyaniderespiration

0.000

NaN30.2-2 mM Sodium aziderespiration

-1.346

Nigericin50 uM Nigericinrespiration

0.077

TRC10-150 ug/mL Triclosanrespiration

0.443

TRZ10-25 ug/mL Thioridazinerespiration

-1.333

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-0.935

menadione6-10 ug/mL Menadionerespiration

1.222

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.110

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.848

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-1.139

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-1.039

NRP_1Non-replicating persistence stage 1dosRassociated

-0.028

Amp0.2mg/mL AmpicillincellWall

-0.441

Cephalexin20-100 ug/mL CephalexincellWall

2.305

Cerulenin0.32-5 ug/mL CerulenincellWall

0.224

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.524

EMB10-20 ug/mL EthambutolcellWall

0.431

Eta12-40 ug/mL EthionamidecellWall

0.134

INH0.2-0.4 ug/mL IsoniazidcellWall

0.926

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.082

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.064

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.209

BZA0.12 mg/mL BenzamidearomaticAmides

-0.283

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.319

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.374

H2O24 mM hydrogen peroxideDNAdamaging

0.726

Levo10 ug/mL LevofloxacinDNAdamaging

0.340

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.981

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.416

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.029

UVUV-irradiationDNAdamaging

-0.794

ARP41-4 ug/mL Antitubercular compound ARP4?

0.622

Antimycin12.5-50 ug/mL Antimycin A?

-0.851

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

1.452

PA_110-50 ug/mL Antitubercular compound PA-1?

1.285

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.691

PA8240.2-2 ug/mL PA-824?

0.660

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.031

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.243

Verapamil50 uM Verapamil?

-1.221

mercaptoethanol2 mM 2-Mercaptoethanol?

-1.269

methoxatin10-20 ug/mL Methoxatin?